share_log

和鉑醫藥-B:董事會會議召開日期

HBM HOLDINGS-B: DATE OF BOARD MEETING

HKEX ·  Aug 5 17:28

Summary by Futu AI

和鉑醫藥-B(02142.HK)將於2024年8月28日(星期三)召開董事會會議,屆時將考慮及通過該集團截至2024年6月30日止六個月的中期業績。會議將由公司主席及執行董事王勁松博士主持。此次會議除了審核中期業績外,還將處理其他事項。
和鉑醫藥-B(02142.HK)將於2024年8月28日(星期三)召開董事會會議,屆時將考慮及通過該集團截至2024年6月30日止六個月的中期業績。會議將由公司主席及執行董事王勁松博士主持。此次會議除了審核中期業績外,還將處理其他事項。
Wobio Pharma-B (02142.HK) will hold a board of directors meeting on Wednesday, August 28, 2024, at which time the group's mid-year performance as of June 30, 2024 will be considered and approved. The meeting will be chaired by the company's chairman and executive director, Dr. Wang Jinsong. In addition to reviewing mid-year performance, other matters will also be addressed at this meeting.
Wobio Pharma-B (02142.HK) will hold a board of directors meeting on Wednesday, August 28, 2024, at which time the group's mid-year performance as of June 30, 2024 will be considered and approved. The meeting will be chaired by the company's chairman and executive director, Dr. Wang Jinsong. In addition to reviewing mid-year performance, other matters will also be addressed at this meeting.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.